Combined-modality therapy for head and neck cancer

ONCOLOGY

Volumn 11, Issue 12, 1997, Pages 1781-1796

  Fu, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; HYDROCORTISONE; METHOTREXATE; METHYLPREDNISOLONE; MITOMYCIN C; VINCRISTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; LARYNX CARCINOMA; METASTASIS; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; PHASE 3 CLINICAL TRIAL; REVIEW; SQUAMOUS CELL CARCINOMA;

CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; FORECASTING; HEAD AND NECK NEOPLASMS; HUMANS; LARYNX; NASOPHARYNGEAL NEOPLASMS;

EID: 0031442745     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991.
2. Lefebvre JL, Chevalier D, Lubomski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial: EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996
3. Fu KK, Phillips TL: Biologic rationale of combined radiotherapy and chemotherapy, Hematol Oncol Clin North Am 5.737-751, 1991.
4. Milas L, Milross CG, Mason KA: Cytotoxic treatments and tumor oxygenation. Cancer J Sci Am 2:59-60, 1996.
5. Milas L, Hunter NR, Mason KA, et al: Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54:3506-3510, 1994.
6. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program. Cancer 60:301-311, 1987.
7. Rentschler RE, Wilbur DW, Petti GH, et al: Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas - a prospective, randomized study. J Clin Oncol 5:278-285, 1987
8. Schuller DE, Metch B, Stein DW, et al: Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98 1205-1211, 1988.
9. Jotay A, Demard F, Dalesio O, et al: A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolarygectomy and irradiation: Results from 5 to 10 years. Acta Chir Belg 90:115-122, 1990
10. Richard JM, Kramer A, Molinari R, et al: Randomized EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 27:821-827, 1991
11. Wolfe GT, Hong WK, Fisher SG: Neoadjuvant chemotherapy for organ preservation: Current status, in Shah JP, Johnson JT (eds): 4th International Conference on Head and Neck Cancer, pp 89-97. Toronto, Canada, The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery, 1996.
12. Depondt J, Gehanno P, Martin M, et al: Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 50.23-27, 1993.
13. Di Blasio B, Barieri W, Bozzetti A, et al: A prospective randomized tria! in resectable head and neck carcinoma loco-regional treatment with and without neoadjuvant chemotherapy (abstract). Proc Am Soc Clin Oncol 13:286, 1994.
14. Volling P, Schroeder M, Eckel H, et al: Results of a prospective randomized trial with induction chemotherapy in cancer of the oral cavity and the pharynx (abstract), in 4th International Conference on Head and Neck Cancer, p 179. Toronto, Canada, The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery, 1996.
15. Arcangeli G, Nervi C, Righim R, et al: Combined radiation and drugs. The effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol 1-101-107, 1983.
16. Stell PM, Dalby JE, Strickland P, et al. Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol 34:463-467, 1983.
17. Taylor SG, Applebaum E, Showel JL, et al: A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 3:672-679, 1985.
18. Stolwijk C, Wagener DJ, Van den Broek P, et al: Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Neth J Med 28:347-351, 1985.
19. Kun LE, Toohill RJ, Holoye PY, et al: A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 12:173-178, 1986.
20. Toohill RJ, Anderson T, Byhardt RW, et al: Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer: A preliminary report. Arch Otolaryngol Head Neck Surg 113:758-761, 1987
21. Martin M, Hazan A, Vergnes L, et al: Randomized study of 5 fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: A preliminary report. Int J Radiat Oncol Biol Phys 19:973-975, 1990.
22. Mazeron J-J, Martin M, Brun B, et al: Induction chemotherapy in head and neck cancer. Head Neck 14.85-91, 1992.
23. Jaulerry C, Rodriguez J, Brunm F, et al: Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials. Int J Radiat Oncol Biol Phys 23:483-489, 1992.
24. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272, 1994
25. Dalley D, Beller E, Aroney R, et at: The value of chemotherapy (CT) prior to definitive local therapy (DLT) in patients with locally advanced squamous cell carcinoma (SCC) of the head and neck (HN) (abstract). Proc of Am Soc Clin Oncol 14:297, 1995.
26. Chan AT, Teo PM, Leung TW, et al: A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33.569-577, 1995.
27. International Nasopharynx Cancer Study Group: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥ N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. VUMCA I trial. Int J Radiat Oncol Biol Phys 35:463-469, 1996
28. Domenge C, Coche-Dequeant B, Wibault P, et al: Randomized trial of neoadjuvant chemotherapy before radiotherapy in oropharyngeal carcinoma (abstract), in 4th International Conference on Head and Neck Cancer, p 99. Toronto, Canada, The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery, 1996.
29. Fu KK, Cooper JS, Marcial VA, et al: Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer. Int J Radiat Oncol Biol Phys 35:425-438, 1996.
30. Lo TC, Wiley AL, Jr., Ansfield FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 126:229-235, 1976.
31. Shanta V, Krishnamurthi S: Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 31:617-620, 1980.
32. Fu KK, Phillips TL, Silverberg IJ, et al: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410-1418, 1987.
33. Gupta NK, Pointon RC, Wilkinson PM: A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 38:575-581, 1987.
34. Weissberg JB, Son YH, Papac RJ, et al: Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer Int J Radiat Oncol Biol Phys 17:3-9, 1989.
35. Sanchiz F, Milla A, Torner J, et al: Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 19:1347-1350, 1990.
36. Bachaud JM, Cohen-Jonathan E, Alzien C, et al: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial. Int J Radiat Oncol Biol Phys 36:999-1004, 1996.
37. Haffty BG, Son YH, Sasaki CT, et al: Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 27:241-250, 1993.
38. Smid L, Lesnicar H, Zakotnik B, et al: Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer - preliminary report. Int J Radiat Oncol Biol Phys 32 769-775, 1995.
39. Adelstein DJ, Saxton JP, Lavertu P, et al: Concurrent radiation and chemotherapy (CT) versus (vs) radiotherapy (RT) alone in resectable stage III and IV squamous cell head and neck cancer (SCHNC): A phase III randomized trial (abstract). Proc Am Soc Clin Oncol 15:26, 1996.
40. Gabriele P, Tessa M, Ragona R, et al: An interim analysis of phase III study on radiotherapy (RT) versus RT plus carboplatin (CBDCA) in inoperable stage IH-IV head and neck (H&N) carcinoma (abstract), in 4th International Conference on Head and Neck Cancer, p 116. Toronto, Canada, The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery, 1996.
41. Wustrow TPU, Wendt TG, Grabenbauer G, et al: Randomized phase III study for simultaneous radiopolychemotherapy in head and neck cancer (abstract), in 4th International Conference on Head and Neck Cancer, p 117. Toronto, Canada, The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery, 1996.
42. Brizel D, Albers M, Fisher S, et al: A phase III trial of hyperfractionated irradiation ± concurrent chemotherapy for locally advanced carcinoma of the head and neck: Superiority of combined modality treatment (abstract). 4th International Conference on Head and Neck Cancer, p 117. Toronto, Canada, The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery, 1996.
43. Al-Sarraf M, Le Blanc M, Gin PGS, et al: Chemo-radiotherapy vs. radiotherapy in patients with locally advanced nasopharyngeal cancerPhase III randomized: Intergroup study (0099) (SWOG 8892, RTOG 8817, ECOG 2388). N Engl J Med. 1997 (in press).
44. Southeast Cooperative Oncology Group: A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck: An interim report from the SECOG participants. Eur J Surg Oncol 12:289-295, 1986.
45. Adelstein DJ, Sharan VM, Earle AS, et al: Simultaneous versus sequential combined tech- nique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691, 1990.
46. Merlano M, Benasso M, Cavallari M, et al: Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. Cancer 67:915-921, 1991.
47. Salvajoli JV, Morioka H, Trippe N, et al: A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous carcinoma EurArch Otorhinolarygology 249:211-215, 1992.
48. Taylor SG, Murthy A, Vannetzel JM, et al: Randomized comparison of neroadjuvant cisplatin and fluorouracil infusin followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994.
49. Pinnaro P, Cercato MC, Giannarelli D, et al: A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck. Ann Oncol 5:513-519, 1994.
50. Merlano M, Vitale V, Rosso R, et al: Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121, 1992.
51. Merlano M, Benasso M, Corvo R, et al: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996.
52. Fowler JF, Lindstrom MJ: Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23:457-467, 1992.
53. Szpirglas H, Chastang C, Bertrand JC: Adjuvant treatment of tongue and floor of the mouth cancers. Recent Results Cancer Res 68:309-317, 1978.
54. Ervin TJ, Clark JR, Weichselbaum RR, et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 5:10-20, 1987.
55. Rossi A, Molinari R, Boracchi P, et al: Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study. J Clin Oncol 6:1401-1410, 1988.
56. Laramore GE, Scott CB, Al-Sarraf M, et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23:705-713, 1992.
57. Fandi A, Cvitkovic E: Biology and treatment of nasopharyngeal cancer. Curr Opin Oncol 7:255-263, 1995.
58. Jacobs C, Makuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8:838-847, 1990.
59. Leibel SA, Scott CB, Mohiuddin M, et al: The effect of local-regional control on distant melastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 21:549-556, 1991.
60. Bradford CR, Zhu S, Wolf GT, et al: Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer: Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol Head Neck Surg 113:408-412, 1995.
61. Roychowdhury DF, Tseng A, Fu KK, et al: New prognostic factors in nasopharyngeal carcinoma. Cancer 77:1419-1426, 1996.
62. Koch WM, Brennan JA, Zahurak M, et al: p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 88:1580-1586, 1996.